BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
AcelRx Pharmaceuticals (ACRX) Announces Publication Of Manuscript Analyzing Cost Of Intravenous Patient-Controlled Analgesia With Opioids 9/10/2014 8:37:50 AM
AcelRx Pharmaceuticals (ACRX) Announces Publication Of Sufentanil Sublingual Tablet System Vs. Intravenous Patient-Controlled Analgesia With Morphine For Postoperative Pain Study Results 9/5/2014 10:39:39 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Two Upcoming Investor Events 8/27/2014 8:22:40 AM
AcelRx Pharmaceuticals (ACRX) Reports Second Quarter 2014 Financial Results 8/12/2014 8:36:47 AM
AcelRx Pharmaceuticals (ACRX) To Participate In Three Upcoming Investor Events 8/8/2014 8:39:27 AM
AcelRx Pharmaceuticals (ACRX) To Hold Second Quarter Financial Results Conference Call And Webcast On Monday, August 11th, 2014 8/7/2014 9:36:27 AM
FDA Rejects Redwood City's AcelRx Pharmaceuticals (ACRX) Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET 7/28/2014 6:17:43 AM
AcelRx Pharmaceuticals (ACRX) Confirms July 27, 2014 PDUFA Date For Zalviso 7/25/2014 9:08:46 AM
AcelRx Pharmaceuticals (ACRX) And Grunenthal Announce Submission Of European Marketing Authorization Application For ZALVISO™ 7/7/2014 8:47:41 AM
AcelRx Pharmaceuticals (ACRX) To Present At The JMP Securities Healthcare Conference 6/19/2014 7:35:38 AM
12345678910...